About us

RubyHealth is being shaped around clearer health records.

The project brings together product, engineering, paediatric, and research experience to make family-observed health patterns easier to review responsibly. We are in beta testing with a planned Q4 2026 launch.

A mission built around longitudinal context.

Parents, caregivers, and clinicians often work with fragmented information: device readings, paper diaries, medication changes, school notes, and short appointment windows. RubyHealth is being designed to organise those signals in one timeline.

The product is not a diagnostic tool. It is a monitoring aid that helps prepare better conversations with qualified clinicians.

Mission

Make everyday health context easier to capture, review, and discuss.

Vision

Support families and clinicians with longitudinal records that respect medical judgement.

Values

Careful claims, practical design, local governance awareness, and research-minded iteration.

Built for PANDAS and Neuroimmune Families

Designed for families managing rapid-onset conditions.

RubyHealth is specifically designed to support families managing PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections), PANDAS-like conditions, and other rapid-onset neurobehavioral syndromes where daily pattern tracking is clinically useful. We focus on helping families and clinicians identify early warning signals, track medication responses, and build longitudinal health records that support informed clinical conversations.

Meet the team

People behind the RubyHealth direction.

Andre Roos

Andre Roos

Chief Executive Officer, steering strategy, partnerships, and growth.

LinkedIn
Pieter Joubert

Pieter Joubert

Chief Financial Officer.

LinkedIn
Prof Pieter Fourie

Prof Pieter Fourie

Chief Technology Officer, bringing paediatric, engineering, and research experience.

LinkedIn

Research partners

Built for careful collaboration.

RubyHealth is relevant to partners working with paediatric, neurodiverse, neuroimmune, and longitudinal care pathways. Research and educational content will be labelled carefully and kept separate from diagnosis or treatment guidance.